Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H4 | Q96RI1 | 20/20 | 0.52 |
| ▸ | LIFR | P42702 | 1/20 | 0.50 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | PPARD | Q03181 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21624449 | 0.90 | NR1H4 (0.58) | NR1H4LIFRNR1I2CYP1A2CYP3A4 | |
| SCHEMBL21624445 | 0.86 | NR1H4 (0.64) | NR1H4LIFRNR1I2CYP1A2CYP3A4 | |
| SCHEMBL30080616 | 0.84 | NR1H4 (0.71) | NR1H4LIFR | |
| SCHEMBL30080704 | 0.74 | NR1H4 (0.80) | NR1H4LIFRNR1I2CYP1A2CYP3A4 | |
| SCHEMBL30080614 | 0.73 | NR1H4 (0.83) | NR1H4LIFRPPARD | |
| SCHEMBL30080743 | 0.71 | NR1H4 (0.88) | NR1H4LIFRNR1I2CYP1A2CYP3A4 | |
| SCHEMBL21624448 | 0.71 | NR1H4 (0.69) | NR1H4LIFRNR1I2CYP1A2CYP3A4 | |
| SCHEMBL21624447 | 0.69 | NR1H4 (0.52) | NR1H4LIFRNR1I2CYP1A2CYP3A4 | |
| SCHEMBL29143449 | 0.67 | NR1H4 (0.74) | NR1H4PPARD | |
| SCHEMBL4603368 | 0.67 | PTPN11 (0.59) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3823960-A1 | ISOXAZOLE AS FXR RECEPTOR AGONISTS | Bar Pharmaceuticals Societa ' A Responsabilita' Limitata (IT) | 2021-05-26 | — | — | EP | disclosed |
| WO-2020016801-A1 | ISOXAZOLE AS FXR RECEPTOR AGONISTS | BAR PHARMACEUTICALS SOCIETA' A RESPONSABILITA' LIMITATA (IT) | 2020-01-23 | — | — | WO | disclosed |